Nominated for the Young Investigator Award at the European Association of Study of Liver (EASL) for the work entititled ' Enhanced renal ammonia excretion following volume expansion is mediated through the renin-angiotensin system' in 2001
Awarded the 1st prize in the plenary presentation at the 41st annual conference of the Indian Society of Gastroenterology at New Delhi, India for the work entitled ‘Endothelin mediates changes in renal and systemic hemodynamics during sudden increase in portal pressure’ in 2001
Awarded the prestigious Dr P N Berry scholarship for training and research in the UK by the P N Berry Trust, Indian High Commission UK. Secured the first position in the merit list of scholars for the year 2000-01.
An evaluation of two dose routes of HDV Interferon (HDV IFN) administered with ribavarin in the treatment of chronic hepatitis C non-responders and treatment naïve patients. HP 01-2006-01 Study.
A Phase II randomized, open label, multi-center therapeutic trial of the efficacy, immunogenicity and safety of GI-5005-an inactivated recombinant Saccharomyces cerevisiae expressing a hepatitis C virus NS3-Core fusion protein, combined with Peg-IFN plus Ribavarin therapy versus standard of care alone in genotype 1 infected patients with chronic hepatitis C.